We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+20.26%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$855M
AUM Growth
-$11.1M
Cap. Flow
-$107M
Cap. Flow %
-12.49%
Top 10 Hldgs %
7.94%
Holding
444
New
121
Increased
37
Reduced
148
Closed
134

Sector Composition

Rank Sector Weight
1 Healthcare 27.83%
2 Technology 22.35%
3 Consumer Discretionary 13.53%
4 Industrials 10.11%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGM
1
DELISTED
Sigma Designs Inc
SIGM
$8.78M 1.03%
736,176
+315,050
+75% +$2.89M
NPTN
2
DELISTED
NEOPHOTONICS CORP
NPTN
$7.53M 0.88%
824,900
+455,256
+123% +$3.45M
USCR
3
DELISTED
U S Concrete, Inc.
USCR
$7.32M 0.86%
193,164
+3,406
+2% +$127K
FOLD
4
DELISTED
Amicus Therapeutics
FOLD
$7.28M 0.85%
514,470
-111,224
-18% -$1.34M
TGTX icon
5
TG Therapeutics
TGTX
$8.58B
$6.81M 0.8%
410,689
+8,814
+2% +$140K
EGRX
6
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6.28M 0.73%
77,602
-77,132
-50% -$5.02M
PRTA icon
7
Prothena Corp
PRTA
$458M
$6.21M 0.73%
117,809
+85,559
+265% +$3.38M
TWOU
8
DELISTED
2U Inc
TWOU
$5.96M 0.7%
6,172
-636
-9% -$528K
AMN icon
9
AMN Healthcare
AMN
$1.27B
$5.89M 0.69%
186,432
-21,514
-10% -$562K
ELLI
10
DELISTED
Ellie Mae Inc
ELLI
$5.77M 0.68%
82,674
+45,924
+125% +$2.86M
GIMO
11
DELISTED
Gigamon Inc.
GIMO
$5.74M 0.67%
173,836
-56,424
-25% -$1.66M
DVAX
12
DELISTED
Dynavax Technologies
DVAX
$5.69M 0.67%
242,886
+55,207
+29% +$1.2M
SGYP
13
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$5.56M 0.65%
+670,346
New +$3.25M
IPHI
14
DELISTED
INPHI CORPORATION
IPHI
$5.49M 0.64%
240,140
-10,258
-4% -$228K
MXL icon
15
MaxLinear
MXL
$6.41B
$5.4M 0.63%
+446,227
New +$4.48M
CBM
16
DELISTED
Cambrex Corporation
CBM
$5.35M 0.63%
121,660
-17,193
-12% -$712K
QTWO icon
17
Q2 Holdings
QTWO
$3.42B
$5.32M 0.62%
188,309
+126,735
+206% +$2.96M
LDRH
18
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$5.26M 0.62%
121,729
-10,987
-8% -$437K
PAYC icon
19
Paycom
PAYC
$6.78B
$5.22M 0.61%
152,883
+117,276
+329% +$4.06M
NVRO
20
DELISTED
NEVRO CORP.
NVRO
$5.21M 0.61%
96,829
-4,910
-5% -$250K
HSKA
21
DELISTED
Heska Corp
HSKA
$5.2M 0.61%
175,086
+37,771
+28% +$1.09M
FIX icon
22
Comfort Systems
FIX
$61B
$5.19M 0.61%
226,255
+162,638
+256% +$3.57M
CALY
23
Callaway Golf Company
CALY
$3.27B
$5.15M 0.6%
575,744
+200,431
+53% +$1.91M
ECHO
24
DELISTED
Echo Global Logistics, Inc.
ECHO
$5.1M 0.6%
+156,173
New +$4.74M
LBY
25
DELISTED
Libbey, Inc.
LBY
$5.02M 0.59%
121,414
+85,270
+236% +$3.45M

Similar funds

EAM Investors's Q2 2015 Portfolio in Review

As of Q2 2015, EAM Investors held 444 positions worth $855M, down 1.3% from $866M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

EAM Investors withdrew a net $107M in Q2 2015, closing 134 positions and reducing 148 holdings. Its most notable exit was Esperion Therapeutics, an estimated $8.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Echo Global Logistics, Inc. worth $5.1M.

  • EAM Investors's largest Q2 2015 buy was Echo Global Logistics, Inc.: 156,173 shares worth $5.1M.
  • EAM Investors added most to Paycom in Q2 2015, an estimated $4.06M increase.
  • EAM Investors's biggest Q2 2015 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $5.02M.
  • EAM Investors fully exited Esperion Therapeutics in Q2 2015, selling an estimated $8.27M.
  • EAM Investors's ten largest holdings make up 7.9% of its $855M portfolio in Q2 2015.
  • EAM Investors opened 121 new positions and closed 134 in Q2 2015.
  • EAM Investors's portfolio value fell 1.3% quarter-over-quarter to $855M.

Based on EAM Investors's 13F filing for Q2 2015, filed 13 Aug 2015.